Imiquimod-induced bullous pemphigoid: A case report.

SAGE Open Med Case Rep

Division of Dermatology, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada.

Published: March 2023

A 72-year-old man treated with 3.5% imiquimod cream for scalp actinic keratoses developed the usual crusted and erosive reaction but developed bullae on the scalp, as well as the limbs and torso after several weeks into treatment. Biopsy confirmed bullous pemphigoid. He was treated with clobetasol ointment, prednisone and methotrexate, with eventual disease control. He had a severe disease course. Bullous pemphigoid is usually idiopathic, but can be induced by skin trauma, as well as by several medications; this is the first report of imiquimod as a trigger. Imiquimod is a toll-like receptor 7 agonist that induces cellular apoptosis and recruits pro-inflammatory cytokines including tumour necrosis factor-alpha and interferon-alpha, which have been implicated in autoimmunity. This case highlights an unusual but severe adverse effect from topical imiquimod.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071145PMC
http://dx.doi.org/10.1177/2050313X231164222DOI Listing

Publication Analysis

Top Keywords

bullous pemphigoid
12
imiquimod-induced bullous
4
pemphigoid case
4
case report
4
report 72-year-old
4
72-year-old man
4
man treated
4
treated 35%
4
imiquimod
4
35% imiquimod
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!